3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Carcinoma, Hepatocellular
131
Liver Neoplasms
42
Carcinoma, Renal Cell
36
Leukemia, Myeloid, Acute
32
Neoplasm Metastasis
26
Breast Neoplasms
24
Carcinoma, Non-Small-Cell Lung
22
Kidney Neoplasms
16
Neoplasms
14
Prostatic Neoplasms
12
Pancreatic Neoplasms
12
Recurrence
11
Lung Neoplasms
11
Colorectal Neoplasms
10
Sarcoma
9
Melanoma
9
Brain Neoplasms
9
Myelodysplastic Syndromes
8
Glioblastoma
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia
6
Urinary Bladder Neoplasms
5
Thyroid Neoplasms
5
Rectal Neoplasms
5
Multiple Myeloma
5
Leukemia, Myelomonocytic, Chronic
5
Stomach Neoplasms
4
Ovarian Neoplasms
4
Liver Diseases
4
Gliosarcoma
4
Interventions
Mitotane
7
Cisplatin
6
pembrolizumab
5
Etoposide
3
Doxorubicin
3
camrelizumab
2
apatinib
2
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Cytoreduction Surgical Procedures
2
sodium thiosulfate
1
iodophenyl metomidate
1
fludarabine phosphate
1
dostarlimab
1
cemiplimab
1
cabozantinib
1
cabazitaxel
1
antineoplaston AS 2-1
1
antineoplaston A10
1
Suramin
1
Sunitinib
1
Streptozocin
1
Sorafenib
1
Radiation
1
Paclitaxel
1
Observation
1
Nivolumab
1
Megestrol Acetate
1
Lymph Node Excision
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Adrenocortical Carcinoma
×
Sorafenib
×
Clear all
NCT00786110
2009-02-24
PAXO
University of Turin, Italy
Phase 2
Unknown
30 enrolled